COMPARISON OF HEPARIN AND ASPIRIN AS ADJUNCTIVE THERAPY WITH TISSUE PLASMINOGEN-ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION - REPLY

被引：0
|
作者：
HSIA, J
ROSS, AM
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1991年 / 324卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1218 / 1218
页数：1
相关论文
共 50 条
  • [31] DOES TISSUE PLASMINOGEN-ACTIVATOR EXACERBATE HEMORRHAGIC MYOCARDIAL-INFARCTION
    KLONER, RA
    ALKER, KJ
    FIGURES, G
    HALE, SL
    EISENHAUER, AC
    CAMPBELL, CA
    ARTERIOSCLEROSIS, 1988, 8 (05): : A706 - A706
  • [32] A PILOT TRIAL OF RECOMBINANT DESULFATOHIRUDIN COMPARED WITH HEPARIN IN CONJUNCTION WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ASPIRIN FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI)-5 TRIAL
    CANNON, CP
    MCCABE, CH
    HENRY, TD
    SCHWEIGER, MJ
    GIBSON, RS
    MUELLER, HS
    BECKER, RC
    KLEIMAN, NS
    HAUGLAND, JM
    ANDERSON, JL
    SHARAF, BL
    EDWARDS, SJ
    ROGERS, WJ
    WILLIAMS, DO
    BRAUNWALD, E
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (05) : 993 - 1003
  • [33] HEMORRHAGIC COMPLICATIONS AFTER TISSUE PLASMINOGEN-ACTIVATOR (T-PA) THERAPY FOR ACUTE MYOCARDIAL-INFARCTION
    CALIFF, RM
    STUMP, D
    THORNTON, D
    KEREIAKES, DJ
    GEORGE, BS
    ABBOTTSMITH, CW
    CANDELLA, RJ
    BOSWICK, JM
    TOPOL, EJ
    CIRCULATION, 1987, 76 (04) : 1 - 1
  • [34] CORRELATION BETWEEN BASE-LINE PLASMINOGEN-ACTIVATOR INHIBITOR LEVELS AND CLINICAL OUTCOME DURING THERAPY WITH TISSUE PLASMINOGEN-ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION
    SANE, DC
    STUMP, DC
    TOPOL, EJ
    SIGMON, KN
    KEREIAKES, DJ
    GEORGE, BS
    MANTELL, SJ
    MACY, E
    COLLEN, D
    CALIFF, RM
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (03) : 275 - 279
  • [35] INTRAVENOUS BOLUS ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR TO PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    TRANCHESI, B
    VERSTRAETE, M
    VANHOVE, P
    VANDEWERF, F
    CHAMONE, DF
    BELLOTTI, G
    PILEGGI, F
    CORONARY ARTERY DISEASE, 1990, 1 (01) : 83 - 88
  • [36] COMMUNITY-HOSPITAL EXPERIENCE WITH RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    AUSTIN, SM
    CARO, M
    GEMMEL, D
    JOURNAL OF GENERAL INTERNAL MEDICINE, 1992, 7 (02) : 187 - 190
  • [37] RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION IN THE CHINESE IN HONG-KONG
    WOO, KS
    TSE, KK
    MAK, YK
    CHUNG, HK
    TSE, CY
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1992, 36 (02) : 169 - 176
  • [38] REDUCED SYNTHESIS OF TISSUE PLASMINOGEN-ACTIVATOR BY VASCULAR ENDOTHELIUM DURING ACUTE MYOCARDIAL-INFARCTION
    NORRIS, RM
    OCKELFORD, PA
    CROSS, DB
    RIVERS, JT
    SMITH, JM
    TAKAYAMA, M
    WHITE, HD
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1992, 22 (03): : 261 - 264
  • [39] A RANDOMIZED DOSE RANGING STUDY OF RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    MCNEILL, AJ
    SHANNON, JS
    CUNNINGHAM, SR
    FLANNERY, DJ
    CAMPBELL, NPS
    KHAN, MM
    PATTERSON, GC
    WEBB, SW
    ADGEY, AAJ
    BRITISH MEDICAL JOURNAL, 1988, 296 (6639): : 1768 - 1771
  • [40] TISSUE PLASMINOGEN-ACTIVATOR (T-PA) IN ACUTE MYOCARDIAL-INFARCTION - NEW POSSIBILITIES
    SCHETTLER, G
    GROSS, R
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 1986, 136 (13) : 337 - 338
12345